- Proven to be a cardiovascular medical institution specializing in stroke prevention therapy for atrial fibrillation patients

Mediplex Sejong Hospital was selected as an institution for percutaneous left atrial appendage occlusion by the Health Insurance Review and Assessment Service again this year after the hospital was first designated so in 2018.

Meeting the requirements of annual performance, personnel, facilities and equipment, Mediplex Sejong Hospital was approved as a medical institution for percutaneous left atrial appendage occlusion for a 1-year period from September 1, 2019 to August 31, 2020.

We at Mediplex Sejong Hospital will do our best to help treat diseases and improve the quality of life of patients by introducing various proven treatments.